Icariin Facilitates Osteogenic Differentiation and Suppresses Adipogenic Differentiation of Bone Marrow Mesenchymal Stem Cells by Enhancing SOST Methylation in Postmenopausal Osteoporosis
The Journal of Gene Medicine · 2025-01 · 27 (1)
DOI: 10.1002/jgm.70010 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Gene Medicine, online erschienen am 22.01.2025. Verfasst von Xu Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen City, Guangdong, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Osteogenesis, Osteoporosis, Postmenopausal, Adipogenesis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Shenzhen Key Laboratory of Bone Tissue Repair and Translational Research.
Abstract (Originalsprache)
Purpose
Postmenopausal osteoporosis (PMO) is mainly concerned with the imbalance of bone resorption and bone formation. Icariin (ICA) plays a vital role in bone protection. This study investigated the mechanism of ICA in PMO rats.
Methods
The rats were treated with ovariectomy (OVX) and ICA. Bone structure parameters were measured by Micro‐CT. BMSCs were obtained from normal rats, OVX rats, and ICA‐treated rats. BMSCs were infected with SOST overexpression lentivirus, and TWS119, an activator of Wnt pathway, was introduced for joint experiment. The binding of ERα to SOST promoter was verified. OVX/ICA rats were injected with DNA methyltransferase inhibitor 5‐Aza‐dC.
Result
ICA increased bone mass and decreased bone marrow fat content in OVX rats. ICA facilitated osteogenic differentiation and repressed adipogenic differentiation of BMSCs. Overexpressing SOST antagonized the effect of ICA, whereas TWS119 rescued the effect of overexpressing SOST. ICA reduced SOST expression by attenuating the effect of ERα. Methylation of SOST inhibited ERα binding to SOST promoter. In vivo experiments confirmed that ICA improved bone mass and reduced bone marrow fat content by enhancing SOST methylation.
Conclusion
Overall, ICA upregulated SOST methylation and inhibited the binding of ERα to SOST promoter, thereby promoting osteogenic differentiation and repressing adipogenic differentiation of BMSCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen City, Guangdong, China.
- Guangdong Provincial Key Laboratory of Orthopedics and Traumatology, Orthopaedic Research Institute, Guangzhou City, China.
- Department of Spinal Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou City, China.
Förderung
- Guangdong Basic and Applied Basic Research Foundation
- Shenzhen Key Laboratory of Bone Tissue Repair and Translational Research
Zitieren
APA
Chen, X., Liu, X., Wan, J., Hu, Y., & Wei, F. (2025). Icariin Facilitates Osteogenic Differentiation and Suppresses Adipogenic Differentiation of Bone Marrow Mesenchymal Stem Cells by Enhancing SOST Methylation in Postmenopausal Osteoporosis. The Journal of Gene Medicine, 27(1). https://doi.org/10.1002/jgm.70010
Vancouver
Chen X, Liu X, Wan J, Hu Y, Wei F. Icariin Facilitates Osteogenic Differentiation and Suppresses Adipogenic Differentiation of Bone Marrow Mesenchymal Stem Cells by Enhancing SOST Methylation in Postmenopausal Osteoporosis. The Journal of Gene Medicine. 2025;27(1). doi:10.1002/jgm.70010
BibTeX
@article{Chen2025,
author = {Chen, Xu and Liu, Xizhe and Wan, Junming and Hu, Yanqing and Wei, Fuxin},
title = {Icariin Facilitates Osteogenic Differentiation and Suppresses Adipogenic Differentiation of Bone Marrow Mesenchymal Stem Cells by Enhancing SOST Methylation in Postmenopausal Osteoporosis},
journal = {The Journal of Gene Medicine},
year = {2025},
volume = {27},
number = {1},
doi = {10.1002/jgm.70010}
}
EUVIMED